Effective Ebola vaccine in 12 months- it took a village, and hard work!

RW Malone MD LLC is proud to have played a key role in enabling the enormous success of developing an effective Ebola vaccine within 12 months. August 2014, colleagues at the Department of Defense/Defense Threat Reduction Agency asked us to step in and help NewLink manage the project and develop the contracts necessary to move the "orphan" PHAC/rVSV ZEBOV vaccine forward quickly. We got the project on track, recruited our client Focus Clinical Trials to team with USAMRIID/WRAIR to develop the immunoassays, put WHO leadership in touch with Pentagon leadership to expedite the initial WRAIR clinical trials, recruited the government of Norway to help fund the clinical research, recruited a management team, and lead the development of the BARDA and DTRA contracts - yielding over 200M$ in resources. Those were frightening times, but now we have a remarkably effective vaccine, developed in record time. The US Army Medical Corps, Medical Countermeasure Systems (MCS) and the DoD Defense Threat Reduction Agency (DTRA) took risks and got the job done, on time and on budget, with little fanfare, and we were grateful to have been able to serve and assist with this huge accomplishment.

 Robert took these photos during the Ebola crisis planning meetings at the World Health Organization last fall. Heads of states, the Director General and Assistant Director General of the WHO, the Assistant Secretary for Preparedness and Response for USA, ambassadors from most major countries -including the USA and UK, and CEOs from most of the major pharma vaccine companies were all there. The meetings were intense, passions were high and the world came together to develop a plan. Scary times.

Robert took these photos during the Ebola crisis planning meetings at the World Health Organization last fall. Heads of states, the Director General and Assistant Director General of the WHO, the Assistant Secretary for Preparedness and Response for USA, ambassadors from most major countries -including the USA and UK, and CEOs from most of the major pharma vaccine companies were all there. The meetings were intense, passions were high and the world came together to develop a plan. Scary times.